nodes	percent_of_prediction	percent_of_DWPC	metapath
Niflumic Acid—PTGS2—Risedronate—osteoporosis	0.776	1	CbGbCtD
Niflumic Acid—PLA2G4A—Estradiol—Estropipate—osteoporosis	0.00622	0.418	CbGdCrCtD
Niflumic Acid—PLA2G4A—Estradiol—Conjugated Estrogens—osteoporosis	0.00471	0.317	CbGdCrCtD
Niflumic Acid—PLA2G4A—Estradiol—Ethinyl Estradiol—osteoporosis	0.00396	0.266	CbGdCrCtD
Niflumic Acid—PLA2G4A—Hemostasis—FGB—osteoporosis	0.000368	0.00176	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPD2—osteoporosis	0.000367	0.00175	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PGLS—osteoporosis	0.000367	0.00175	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CA2—osteoporosis	0.000367	0.00175	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—OXCT1—osteoporosis	0.000367	0.00175	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	0.000366	0.00174	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000363	0.00173	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MGLL—osteoporosis	0.000358	0.00171	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000352	0.00168	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL1B—osteoporosis	0.000352	0.00168	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000347	0.00165	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—LEP—osteoporosis	0.000347	0.00165	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	0.000344	0.00164	CbGpPWpGaD
Niflumic Acid—PTGS2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	0.000341	0.00163	CbGpPWpGaD
Niflumic Acid—UGT1A9—Biological oxidations—POMC—osteoporosis	0.00034	0.00162	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000337	0.00161	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ATIC—osteoporosis	0.000336	0.0016	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PNP—osteoporosis	0.000336	0.0016	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	0.000335	0.0016	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SOST—osteoporosis	0.000324	0.00155	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—IGF1—osteoporosis	0.000323	0.00154	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ENO1—osteoporosis	0.000321	0.00153	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PKM—osteoporosis	0.000321	0.00153	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—FDPS—osteoporosis	0.000321	0.00153	CbGpPWpGaD
Niflumic Acid—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—osteoporosis	0.000319	0.00152	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PSMA2—osteoporosis	0.000317	0.00151	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—PSMA5—osteoporosis	0.000317	0.00151	CbGpPWpGaD
Niflumic Acid—PLA2G4A—PDGFR-beta signaling pathway—MYC—osteoporosis	0.000306	0.00146	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPD2—osteoporosis	0.000304	0.00145	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—IDH2—osteoporosis	0.000304	0.00145	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PGLS—osteoporosis	0.000304	0.00145	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALCR—osteoporosis	0.000293	0.0014	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTH1R—osteoporosis	0.000293	0.0014	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000287	0.00137	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP27A1—osteoporosis	0.000286	0.00136	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—OXCT1—osteoporosis	0.000286	0.00136	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CA2—osteoporosis	0.000286	0.00136	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL1B—osteoporosis	0.000279	0.00133	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PNP—osteoporosis	0.000278	0.00133	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ATIC—osteoporosis	0.000278	0.00133	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MGLL—osteoporosis	0.000278	0.00133	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ACP5—osteoporosis	0.000278	0.00133	CbGpPWpGaD
Niflumic Acid—PTGS1—Biological oxidations—POMC—osteoporosis	0.000277	0.00132	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	0.000268	0.00128	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000262	0.00125	CbGpPWpGaD
Niflumic Acid—SLC16A1—Transmembrane transport of small molecules—ADCY5—osteoporosis	0.000262	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—FDPS—osteoporosis	0.000262	0.00125	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PKM—osteoporosis	0.000262	0.00125	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PTH—osteoporosis	0.00026	0.00124	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—TPI1—osteoporosis	0.000259	0.00123	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—CYP19A1—osteoporosis	0.000257	0.00123	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—TNF—osteoporosis	0.000255	0.00122	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CNR2—osteoporosis	0.000254	0.00121	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPD2—osteoporosis	0.000248	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PGLS—osteoporosis	0.000248	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—SOST—osteoporosis	0.000248	0.00118	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PKM—osteoporosis	0.000248	0.00118	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—P4HB—osteoporosis	0.000243	0.00116	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GAPDH—osteoporosis	0.000239	0.00114	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—WNT1—osteoporosis	0.000239	0.00114	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—IDH2—osteoporosis	0.000237	0.00113	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—OXCT1—osteoporosis	0.000237	0.00113	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CA2—osteoporosis	0.000237	0.00113	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ANTXR2—osteoporosis	0.000235	0.00112	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PGLS—osteoporosis	0.000235	0.00112	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MGLL—osteoporosis	0.000233	0.00111	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—RAP1A—osteoporosis	0.000233	0.00111	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MGLL—osteoporosis	0.000231	0.0011	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	0.000228	0.00109	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LRP5—osteoporosis	0.000227	0.00108	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ATIC—osteoporosis	0.000227	0.00108	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PNP—osteoporosis	0.000227	0.00108	CbGpPWpGaD
Niflumic Acid—PTGS2—C-MYB transcription factor network—MYC—osteoporosis	0.000226	0.00108	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	0.000225	0.00107	CbGpPWpGaD
Niflumic Acid—UGT1A9—NRF2 pathway—TGFB1—osteoporosis	0.000224	0.00107	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP27A1—osteoporosis	0.000222	0.00106	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL1B—osteoporosis	0.000221	0.00105	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000218	0.00104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000218	0.00104	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000217	0.00104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LRP6—osteoporosis	0.000217	0.00104	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ACP5—osteoporosis	0.000216	0.00103	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—PTHLH—osteoporosis	0.000216	0.00103	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—IGF1—osteoporosis	0.000214	0.00102	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000214	0.00102	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—ADCY5—osteoporosis	0.00021	0.001	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—GPX1—osteoporosis	0.000209	0.000998	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PKM—osteoporosis	0.000208	0.000991	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—FDPS—osteoporosis	0.000208	0.000991	CbGpPWpGaD
Niflumic Acid—PTGS1—Selenium Micronutrient Network—IL6—osteoporosis	0.000206	0.000983	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000203	0.00097	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—TNF—osteoporosis	0.000203	0.000967	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—TPI1—osteoporosis	0.000201	0.00096	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GSN—osteoporosis	0.0002	0.000954	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PGLS—osteoporosis	0.000197	0.00094	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPD2—osteoporosis	0.000197	0.00094	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—IDH2—osteoporosis	0.000196	0.000936	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	0.000195	0.000929	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	0.000194	0.000925	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—MTHFR—osteoporosis	0.000193	0.000921	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—OXCT1—osteoporosis	0.000193	0.00092	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CA2—osteoporosis	0.000193	0.00092	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—CALCA—osteoporosis	0.00019	0.000907	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—P4HB—osteoporosis	0.000189	0.000903	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MGLL—osteoporosis	0.000188	0.000897	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ENO1—osteoporosis	0.000188	0.000897	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GAPDH—osteoporosis	0.000186	0.000886	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PSMA2—osteoporosis	0.000185	0.000884	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—PSMA5—osteoporosis	0.000185	0.000884	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP27A1—osteoporosis	0.000184	0.00088	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TLN1—osteoporosis	0.000183	0.000875	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—RAP1A—osteoporosis	0.000181	0.000863	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PNP—osteoporosis	0.00018	0.000859	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ATIC—osteoporosis	0.00018	0.000859	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ACP5—osteoporosis	0.000179	0.000856	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000177	0.000846	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000177	0.000845	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LRP5—osteoporosis	0.000174	0.00083	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—MYC—osteoporosis	0.000172	0.000821	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TGFB1—osteoporosis	0.000172	0.000819	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—TPI1—osteoporosis	0.000167	0.000795	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—IGF1—osteoporosis	0.000167	0.000795	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LRP6—osteoporosis	0.000166	0.000794	CbGpPWpGaD
Niflumic Acid—PTGS2—Selenium Micronutrient Network—IL6—osteoporosis	0.000164	0.000781	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—TNF—osteoporosis	0.00016	0.000765	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—IDH2—osteoporosis	0.00016	0.000763	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—RPL24—osteoporosis	0.00016	0.000763	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—LTF—osteoporosis	0.00016	0.000763	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—P4HB—osteoporosis	0.000158	0.000755	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000158	0.000752	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—P4HB—osteoporosis	0.000157	0.000748	CbGpPWpGaD
Niflumic Acid—PLA2G1B—Metabolism—POMC—osteoporosis	0.000154	0.000736	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTH—osteoporosis	0.000154	0.000734	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GAPDH—osteoporosis	0.000154	0.000734	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CA2—osteoporosis	0.000153	0.000731	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—OXCT1—osteoporosis	0.000153	0.000731	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—RAP1A—osteoporosis	0.000151	0.000722	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP27A1—osteoporosis	0.00015	0.000717	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—CYP19A1—osteoporosis	0.00015	0.000717	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CNR2—osteoporosis	0.00015	0.000715	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—RAP1A—osteoporosis	0.00015	0.000715	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MGLL—osteoporosis	0.000149	0.000712	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—NFATC1—osteoporosis	0.000147	0.000704	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—DKK1—osteoporosis	0.000146	0.000698	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ACP5—osteoporosis	0.000146	0.000698	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ENO1—osteoporosis	0.000146	0.000698	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000144	0.000689	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PSMA2—osteoporosis	0.000144	0.000687	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—PSMA5—osteoporosis	0.000144	0.000687	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—WNT1—osteoporosis	0.000141	0.000673	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	0.000141	0.000671	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ACP5—osteoporosis	0.000139	0.000661	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGA—osteoporosis	0.000137	0.000654	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—TPI1—osteoporosis	0.000136	0.000648	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—ADCY5—osteoporosis	0.000135	0.000645	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000131	0.000624	CbGpPWpGaD
Niflumic Acid—PTGS2—Spinal Cord Injury—IL6—osteoporosis	0.000129	0.000617	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TPI1—osteoporosis	0.000129	0.000615	CbGpPWpGaD
Niflumic Acid—SLC16A1—Hemostasis—TGFB1—osteoporosis	0.000128	0.000613	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—P4HB—osteoporosis	0.000128	0.00061	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—BMP2—osteoporosis	0.000127	0.000608	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PTHLH—osteoporosis	0.000127	0.000608	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—IDH2—osteoporosis	0.000127	0.000605	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GAPDH—osteoporosis	0.000125	0.000598	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—FGB—osteoporosis	0.000125	0.000595	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—ADCY5—osteoporosis	0.000123	0.000586	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—GPX1—osteoporosis	0.000122	0.000584	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—RAP1A—osteoporosis	0.000122	0.000583	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ENO1—osteoporosis	0.000121	0.000578	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—P4HB—osteoporosis	0.000121	0.000578	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PSMA2—osteoporosis	0.00012	0.000575	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—PSMA5—osteoporosis	0.00012	0.000575	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PSMA2—osteoporosis	0.000119	0.00057	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—PSMA5—osteoporosis	0.000119	0.00057	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP27A1—osteoporosis	0.000119	0.000569	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—GAPDH—osteoporosis	0.000119	0.000567	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	0.000117	0.000559	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—CYP19A1—osteoporosis	0.000117	0.000558	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	0.000117	0.000557	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ACP5—osteoporosis	0.000116	0.000554	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	0.000115	0.000547	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—NFATC1—osteoporosis	0.000113	0.000539	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—MTHFR—osteoporosis	0.000113	0.000539	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—CALCA—osteoporosis	0.000112	0.000536	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—DKK1—osteoporosis	0.000112	0.000535	CbGpPWpGaD
Niflumic Acid—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	0.000109	0.00052	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—WNT1—osteoporosis	0.000108	0.000515	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—TPI1—osteoporosis	0.000108	0.000515	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	0.000107	0.000508	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—FGA—osteoporosis	0.000105	0.000501	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—KL—osteoporosis	0.000102	0.000486	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—P4HB—osteoporosis	0.000101	0.000484	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Hemostasis—TGFB1—osteoporosis	9.99e-05	0.000477	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GAPDH—osteoporosis	9.96e-05	0.000475	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—POMC—osteoporosis	9.94e-05	0.000474	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ENO1—osteoporosis	9.87e-05	0.000471	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PSMA5—osteoporosis	9.73e-05	0.000464	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—PSMA2—osteoporosis	9.73e-05	0.000464	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6R—osteoporosis	9.7e-05	0.000463	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—RAP1A—osteoporosis	9.7e-05	0.000463	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—CYP19A1—osteoporosis	9.68e-05	0.000462	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—ADCY5—osteoporosis	9.55e-05	0.000456	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—GPX1—osteoporosis	9.51e-05	0.000454	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ENO1—osteoporosis	9.36e-05	0.000447	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PSMA2—osteoporosis	9.22e-05	0.00044	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—PSMA5—osteoporosis	9.22e-05	0.00044	CbGpPWpGaD
Niflumic Acid—SLC16A1—Metabolism—POMC—osteoporosis	9.03e-05	0.000431	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—MTHFR—osteoporosis	8.78e-05	0.000419	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—CALCA—osteoporosis	8.59e-05	0.00041	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	8.46e-05	0.000404	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ADCY5—osteoporosis	7.98e-05	0.000381	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—ADCY5—osteoporosis	7.91e-05	0.000378	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—CYP19A1—osteoporosis	7.89e-05	0.000377	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—GPX1—osteoporosis	7.88e-05	0.000376	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ENO1—osteoporosis	7.84e-05	0.000374	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—KL—osteoporosis	7.8e-05	0.000372	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—SPP1—osteoporosis	7.72e-05	0.000369	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PSMA2—osteoporosis	7.72e-05	0.000369	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—PSMA5—osteoporosis	7.72e-05	0.000369	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—MTHFR—osteoporosis	7.28e-05	0.000347	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Metabolism—POMC—osteoporosis	7.02e-05	0.000335	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IRS2—osteoporosis	6.98e-05	0.000333	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—LEP—osteoporosis	6.84e-05	0.000326	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—ESR1—osteoporosis	6.53e-05	0.000311	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—ADCY5—osteoporosis	6.45e-05	0.000308	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—GPX1—osteoporosis	6.43e-05	0.000307	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—CYP19A1—osteoporosis	6.27e-05	0.000299	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—ADCY5—osteoporosis	6.11e-05	0.000292	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IRS1—osteoporosis	6.1e-05	0.000291	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—MTHFR—osteoporosis	5.93e-05	0.000283	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—POMC—osteoporosis	5.87e-05	0.00028	CbGpPWpGaD
Niflumic Acid—UGT1A9—Metabolism—POMC—osteoporosis	5.82e-05	0.000278	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6R—osteoporosis	5.73e-05	0.000273	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IGF1—osteoporosis	5.65e-05	0.00027	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MTHFR—osteoporosis	5.62e-05	0.000268	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IRS2—osteoporosis	5.35e-05	0.000255	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—ADCY5—osteoporosis	5.12e-05	0.000244	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—GPX1—osteoporosis	5.1e-05	0.000243	CbGpPWpGaD
Niflumic Acid—PTGS1—Metabolism—POMC—osteoporosis	4.74e-05	0.000226	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—MTHFR—osteoporosis	4.71e-05	0.000225	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IRS1—osteoporosis	4.67e-05	0.000223	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6R—osteoporosis	4.39e-05	0.000209	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling by GPCR—IL6—osteoporosis	4.32e-05	0.000206	CbGpPWpGaD
Niflumic Acid—PTGS2—Metabolism—POMC—osteoporosis	3.77e-05	0.00018	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—MYC—osteoporosis	3.39e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—TGFB1—osteoporosis	3.39e-05	0.000162	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—MYC—osteoporosis	2.6e-05	0.000124	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—TGFB1—osteoporosis	2.59e-05	0.000124	CbGpPWpGaD
Niflumic Acid—PLA2G4A—Signaling Pathways—IL6—osteoporosis	2.55e-05	0.000122	CbGpPWpGaD
Niflumic Acid—PTGS2—Disease—IL6—osteoporosis	1.95e-05	9.32e-05	CbGpPWpGaD
